- Home
- AMRN vs TKNO Comparison
AMRN vs TKNO Comparison
Compare AMRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMRN | TKNO |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 342.8M | 308.3M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AMRN | TKNO |
|---|---|---|
| Price | $14.89 | $5.37 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 83.3K | ★ 228.2K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.00 | 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,104,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | $1.26 | $13.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | 7.35 |
| 52 Week Low | $12.96 | $1.91 |
| 52 Week High | $20.90 | $6.68 |
Technical Indicators
Market Signals| Indicator | AMRN | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 55.21 |
| Support Level | $14.76 | $4.79 |
| Resistance Level | $15.09 | $5.84 |
| Average True Range (ATR) | 0.80 | 0.43 |
| MACD | -0.17 | -0.06 |
| Stochastic Oscillator | 9.43 | 43.93 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.